Description
Stanozolol Tablets (2 mg)
Healthy Inc is a specialized global supplier and exporter of advanced endocrinological, hormonal, and orphan-disease therapeutics. We provide ultra-high-purity, pharmacopeially validated Stanozolol Tablets (2 mg), manufactured in WHO–GMP certified, strictly dedicated androgenic and hormonal isolation facilities. This “Anabolic-Androgenic Steroid (AAS)” is a highly regulated, critical-care export to specialized immunology clinics, endocrinology centers, and government health ministries in LATAM, the Middle East, Africa, and Southeast Asia, serving as a globally recognized intervention for the prophylactic management of Hereditary Angioedema (HAE).
Product Overview
This formulation contains Stanozolol, a synthetic derivative of testosterone. Its chemical structure has been uniquely altered to heavily favor anabolic (tissue-building) activity while significantly reducing its androgenic (masculinizing) side effects compared to raw testosterone.
The “Hereditary Angioedema & Anabolic” Specialist:
- Mechanism 1 (Hereditary Angioedema Prophylaxis): HAE is a rare, life-threatening genetic disorder characterized by severe, spontaneous swelling of the face, limbs, airway, and intestinal tract due to a deficiency in the C1 esterase inhibitor protein. Stanozolol powerfully stimulates the liver to synthesize increased levels of this exact C1 esterase inhibitor. By correcting this protein deficiency, it effectively prevents the massive release of bradykinin, physically stopping the fatal swelling attacks before they begin.
- Mechanism 2 (The Anabolic Shift): Stanozolol possesses a unique pyrazole ring attached to the steroid nucleus. This gives it an exceptionally high anabolic-to-androgenic ratio. While it binds to androgen receptors to stimulate protein synthesis and nitrogen retention, its masculinizing effects are lower than other traditional steroids.
- The 17-Alpha-Alkylation (Bioavailability vs. Toxicity): Natural testosterone is destroyed by the liver if swallowed. Stanozolol has been structurally altered at the 17th carbon position (17-alpha-alkylated). This chemical armor allows the drug to survive the “first-pass” metabolism of the liver, making it highly effective as an oral 2 mg tablet. However, this exact modification is what makes the drug inherently toxic to the liver during prolonged use.
Product Composition & Strength
We supply this product as a Precision-Blended Uncoated or Film-Coated Tablet, packed in highly secure, moisture-resistant and child-resistant Alu-PVC or Alu-Alu blister strips to ensure the stability of the active hormonal ingredient.
| Active Ingredient | Strength | Primary Clinical Function |
|---|---|---|
| Stanozolol USP/Ph.Eur. | 2 mg | Clinical Standard: Targeted oral anabolic therapy for the prophylaxis of Hereditary Angioedema (HAE). |
| Excipients | Lactose Monohydrate / Microcrystalline Cellulose / Magnesium Stearate / Starch | Diluent / Binder / Lubricant (Engineered for immediate gastric dispersion and reliable systemic absorption) |
*Pack Sizes: 10×10 Blisters or Bottles of 100 (Optimized specifically for strict clinical dispensing under controlled substance regulations).
Technical & Logistics Specifications
Critical data for Pharmaceutical Importers, Endocrinology Distributors, and Customs Authorities.
| HS Code | 3004.39.00 (Medicaments containing hormones or other products of heading 29.37) |
| CAS Number | 10418-03-8 |
| Dosage Form | Tablet (Immediate Release) |
| Regulatory Classification | CONTROLLED SUBSTANCE (CRITICAL). Subject to strict international narcotics and psychotropic substance controls. Export requires valid Import Certificates from the destination country’s Ministry of Health and export permits from the manufacturing jurisdiction. |
| Storage | Store strictly below 30°C in a dry place. Protect from Light. Secure in a controlled-access pharmacy vault. |
| Certificates | WHO-GMP, COPP, Free Sale Certificate |
Manufacturing Authority
Marketed and Distributed by Healthy Inc from WHO-GMP & ISO 9001:2015 certified units.
- Dedicated Androgen Isolation (CRITICAL COMPLIANCE): Because Stanozolol is a highly potent anabolic-androgenic steroid, manufacturing it on standard generic lines risks catastrophic cross-contamination, which could cause unintended virilization in patients taking other drugs. Our manufacturing is executed within strictly segregated, highly controlled hormonal blocks operating under negative pressure with multi-stage HEPA filtration, fully satisfying the stringent requirements of international health ministries.
Therapeutic Indications (Human Use)
Indicated strictly for targeted clinical use under specialist supervision:
- Hereditary Angioedema (HAE): Prophylactic treatment to decrease the frequency and severity of attacks of angioedema.
- Note: Use as a performance-enhancing drug (PED) is illegal and strictly contraindicated.
Dosage & Administration
Recommended Dosage (Strictly as per Specialist/Endocrinologist Guidelines):
- Adults (HAE Prophylaxis): The initial requirement is highly individualized. It typically begins at 2 mg three times a day. Once the swelling attacks are controlled, the dosage is strictly titrated downward at intervals of 1 to 3 months to a maintenance dose of 2 mg once a day or 2 mg every alternate day to minimize hepatotoxicity.
- Administration: Taken orally with or without food.
Safety Warnings (CRITICAL Regulatory & Clinical Data):
- BLACK BOX EQUIVALENT (Peliosis Hepatis & Liver Tumors): 17-alpha-alkylated steroids like Stanozolol cause severe, life-threatening liver toxicity. This includes peliosis hepatis (blood-filled cysts in the liver) and hepatic tumors. These are often asymptomatic until life-threatening intra-abdominal hemorrhage occurs. Routine liver function tests (LFTs) are strictly mandatory.
- Severe Lipid Alteration (Cardiovascular Risk): Stanozolol catastrophically alters the lipid profile. It severely crushes HDL (“good”) cholesterol and spikes LDL (“bad”) cholesterol, massively accelerating atherosclerosis and increasing the risk of coronary artery disease and heart attacks.
- Virilization in Women: Can cause permanent masculinizing side effects in females, including deepening of the voice, hirsutism (facial hair growth), clitoral enlargement, and menstrual irregularities. Therapy must be stopped immediately if mild virilization occurs to prevent irreversible changes.
- Prostate Hypertrophy & Carcinoma: Strictly contraindicated in male patients with carcinoma of the breast or suspected carcinoma of the prostate, as androgens will actively fuel the growth of these tumors.
- Pregnancy (Teratogenic): Strictly contraindicated in pregnancy (Category X). It will cause severe masculinization of a female fetus.
Global Export & Contract Manufacturing Services
Healthy Inc stands as a premier Pharmaceutical Exporter in India, dedicated to serving the needs of international Pharma Traders, Wholesalers, and Retail Pharmacy Networks. As a verified Medicine Supplier in Mumbai, we offer flexible Third Party Manufacturing (Contract Manufacturing) services for Advanced Hormonal and Orphan-Disease Formulations, allowing brands to launch high-quality generic medicines under their own label. Whether you are looking for a reliable Specialty Clinic Supplier in Africa or a B2B Pharma Marketplace partner for Latin America, our logistics network ensures strictly compliant, timely delivery. We actively support Pharmaceutical Bulk Indenting, ensuring that every Authorized Medicine Wholesaler receives WHO-GMP certified products at competitive rates.









Reviews
There are no reviews yet.